June 2020 - Page 211 of 383

TSX Venture News - June 15, 2020

African Gold Group Announces Board and Senior Management Restructuring and Name Change as It Moves Into the Construction Phase

Danny Callow appointed as President and Chief Executive Officer;Scott Eldridge appointed as Non-Executive Chairman of the Board;Jan-Erik Back appointed as […]

NASDAQ Companies - June 14, 2020

Pilgrim’s CEO on Paid Leave of Absence

GREELEY, Colo., June 14, 2020 (GLOBE NEWSWIRE) — Pilgrim’s Pride Corporation (NASDAQ: PPC) today announced that president and CEO Jayson […]

NASDAQ Companies - June 14, 2020

Esperion Announces Pooled Analysis from Phase 3 LDL-C Lowering Clinical Development Program of NEXLETOL™ (Bempedoic Acid) Tablets Presented at the American Diabetes Association 80th Scientific Sessions

ANN ARBOR, Mich., June 14, 2020 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced that pooled analysis from four Phase […]

NASDAQ Companies - June 13, 2020

Investigator-Initiated Study Shows Switching to Afrezza® Improves Glucose Control with No Additional Hypoglycemia in T2DM

WESTLAKE VILLAGE, Calif., June 13, 2020 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD) announced that data from a new clinical […]

NASDAQ Companies - June 13, 2020

Lexicon Pharmaceuticals Presents Clinical Data at 80th American Diabetes Association Scientific Sessions

THE WOODLANDS, Texas, June 13, 2020 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today presented six posters for ZynquistaTM […]

NASDAQ Companies - June 13, 2020

Zealand Pharma presents elaborated results on the use of regular human insulin delivered by V-Go® in older adults with type 2 diabetes, at the 80th Scientific Sessions of the American Diabetes Association

Press release – No. 08 / 2020Zealand Pharma presents elaborated results on the use of regular human insulin delivered by […]

NASDAQ Companies - June 13, 2020

vTv Therapeutics Presents Two Late-Breaking Poster Sessions on Simplici-T1 Study at the American Diabetes Association’s Virtual Sessions Supporting the Potential of TTP399 as First-in-Class Oral Adjunctive Therapy for Type 1 Diabetes Patients

– Treatment with TTP399 resulted in significant improvements in HbA1c with reduction in insulin, without increasing risk of hypoglycemia or […]

NYSE Companies - June 13, 2020

Medtronic Shares Study Results on First of Its Kind Extended Wear Infusion Set from American Diabetes Association Conference

DUBLIN, June 13, 2020 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced data on its […]

NASDAQ Companies - June 13, 2020

Zosano Pharma to showcase new post-hoc analyses of Qtrypta’s (M207) clinical trial data comparing key efficacy results from the pivotal study and the open-label long term safety study on the 2020 American Headache Society’s Virtual Annual Scientific Meeting Platform

FREMONT, Calif., June 13, 2020 (GLOBE NEWSWIRE) — Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that new […]

Canadian Stock Exchange News - June 12, 2020

SHARC™ International Reports on Q1 2020

VANCOUVER, British Columbia, June 12, 2020 (GLOBE NEWSWIRE) — SHARC™ International Systems Inc. (CSE: SHRC) (FSE: IWIA) (OTCQB: INTWF) (“SHARC […]